12 June 2024
Clean Power Hydrogen plc
("CPH2", the "Company" or the "Group")
Holdings in Company
CPH2, the UK-based green hydrogen technology and manufacturing company that has developed the IP-protected Membrane-Free Electrolyser ("MFE") has been informed that Dr Nigel Williamson has transferred 14,000,000 shares to The Nigel Williamson Family Trust.
Following the transaction, The Nigel Williamson Family Trust holds 5.22% interest in the Company and Dr Williamson retains 3.78% interest in the Company.
ENDS
For more information, please contact:
|
Clean Power Hydrogen plc |
via Camarco |
|
Jon Duffy, Chief Executive Officer |
|
|
James Hobson, Chief Financial Officer |
|
|
Cavendish Capital Markets Limited - NOMAD & Broker |
|
|
Neil McDonald |
+44 (0)131 220 9771 |
|
Peter Lynch |
+44 (0)131 220 9772 |
|
Adam Rae |
+44 (0)131 220 9778 |
|
Camarco PR |
+ 44(0) 20 3757 4980 |
|
Billy Clegg |
|
|
Owen Roberts |
|
|
Lily Pettifar |
To find out more, please visit: https://www.cph2.com
Overview of CPH2
CPH2 is the holding company of Clean Power Hydrogen Group Limited ("Clean Power") which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2.